FI47358B - - Google Patents

Info

Publication number
FI47358B
FI47358B FI01801/71A FI180171A FI47358B FI 47358 B FI47358 B FI 47358B FI 01801/71 A FI01801/71 A FI 01801/71A FI 180171 A FI180171 A FI 180171A FI 47358 B FI47358 B FI 47358B
Authority
FI
Finland
Application number
FI01801/71A
Other languages
Finnish (fi)
Other versions
FI47358C (fi
Inventor
Wartburg A Von
M Kuhn
C Keller
J Renz
Original Assignee
Sandoz Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz Ag filed Critical Sandoz Ag
Publication of FI47358B publication Critical patent/FI47358B/fi
Application granted granted Critical
Publication of FI47358C publication Critical patent/FI47358C/fi

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D493/00Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
    • C07D493/02Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
    • C07D493/04Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04Heterocyclic radicals containing only oxygen as ring hetero atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
FI711801A 1965-12-14 1971-06-24 Menetelmä terapeuttisesti käytettävän 4'-demetyyli-epipodofyllotoksiin i-beta-D-glukosidin valmistamiseksi. FI47358C (fi)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
CH1722965 1965-12-14
CH1723265A CH469000A (de) 1965-12-14 1965-12-14 Verfahren zur Herstellung neuer Glucoside
CH1723065A CH507934A (de) 1965-12-14 1965-12-14 Verfahren zur Herstellung eines neuen Glucosids
CH1470366 1966-10-12

Publications (2)

Publication Number Publication Date
FI47358B true FI47358B (es) 1973-07-31
FI47358C FI47358C (fi) 1973-11-12

Family

ID=27429581

Family Applications (2)

Application Number Title Priority Date Filing Date
FI663294A FI47357C (fi) 1965-12-14 1966-12-12 Menetelmä terapeuttisesti vaikuttavien 4'-demetyyli-epipodofyllotoksii ni-beta-D-glukosidin johdannaisten valmistamiseksi.
FI711801A FI47358C (fi) 1965-12-14 1971-06-24 Menetelmä terapeuttisesti käytettävän 4'-demetyyli-epipodofyllotoksiin i-beta-D-glukosidin valmistamiseksi.

Family Applications Before (1)

Application Number Title Priority Date Filing Date
FI663294A FI47357C (fi) 1965-12-14 1966-12-12 Menetelmä terapeuttisesti vaikuttavien 4'-demetyyli-epipodofyllotoksii ni-beta-D-glukosidin johdannaisten valmistamiseksi.

Country Status (15)

Country Link
AT (2) AT295048B (es)
BE (1) BE691066A (es)
CH (2) CH507934A (es)
DK (2) DK120849B (es)
ES (1) ES334424A1 (es)
FI (2) FI47357C (es)
FR (1) FR6310M (es)
GB (1) GB1163106A (es)
IL (3) IL27042A (es)
NL (1) NL6617379A (es)
NO (1) NO120371B (es)
OA (1) OA02648A (es)
SE (2) SE337595B (es)
SU (1) SU414788A3 (es)
YU (1) YU33197B (es)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4713246A (en) * 1984-03-19 1987-12-15 Bristol-Myers Company Etoposide oral dosage form
US4965348A (en) * 1989-05-19 1990-10-23 Bristol-Myers Company Dimeric epipodophyllotoxin glucoside derivatives
US5036055A (en) * 1989-06-07 1991-07-30 Bristol-Myers Company Acylated derivatives of etoposide

Also Published As

Publication number Publication date
YU33197B (en) 1976-06-30
SU414788A3 (es) 1974-02-05
YU233166A (en) 1975-12-31
ES334424A1 (es) 1968-03-01
SE370072B (es) 1974-09-30
SE337595B (es) 1971-08-16
AT298681B (de) 1972-05-25
DK118826B (da) 1970-10-12
NL6617379A (es) 1967-06-15
FI47357B (es) 1973-07-31
CH469000A (de) 1969-02-28
FI47358C (fi) 1973-11-12
IL34853A0 (en) 1970-09-17
GB1163106A (en) 1969-09-04
DK120849B (da) 1971-07-26
FI47357C (fi) 1973-11-12
CH507934A (de) 1971-05-31
IL34853A (en) 1971-04-28
NO120371B (es) 1970-10-12
IL27042A (en) 1971-04-28
BE691066A (es) 1967-06-12
FR6310M (es) 1968-09-16
AT295048B (de) 1971-12-27
OA02648A (fr) 1970-12-15

Similar Documents

Publication Publication Date Title
DK142227C (es)
JPS4218350Y1 (es)
FR6310M (es)
JPS423672Y1 (es)
JPS4515014Y1 (es)
JPS4324674Y1 (es)
JPS476685Y1 (es)
JPS4321827Y1 (es)
JPS445073Y1 (es)
BE675369A (es)
BE675146A (es)
BE670553A (es)
NL6504285A (es)
BE687132A (es)
BE685939A (es)
BE682267A (es)
BE675546A (es)
BE675472A (es)
BE675459A (es)
BE675440A (es)
BE675392A (es)
BE675164A (es)
BE675243A (es)
BE675221A (es)
BE675218A (es)